J Diabetes Res 2018:1232583 Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V (2020) Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment
The CDC called for healthcare providers report any patient who meets the case definition to local, state and territorial health departments so data can be collected to enhance knowledge of risk factors, pathogenesis, clinical course and treatment of this syndrome
TL;DR Summary: Health Journey GLP-1 Booster is a probiotic blend for gut support and appetite control
Check for drug interactions - Some prescriptions, like proton pump inhibitors, can impact B12 absorption and may need to be changed
The alarmingly high prevalence of obesity necessitates the need for more effective anti-obesity medications
